About EasyCheck360
EasyCheck360 is a Healthcare company based in Nashik (India) founded in 2020 by Rajan Datar. It provides blood tests for early cancer screening, diagnosis, and treatment monitoring. It operates on a B2C and B2B model. Its Indian entity Datar Cancer Genetics Private Limited reported revenue of ₹102 Cr. EasyCheck360 offers products and services including EasyCheck360, Cancertrack, and Exacta. Its focus areas include Biotech, Therapeutics, Treatment Monitoring and Diagnostics.
Company details
Datar Cancer Genetics specializes in developing and providing non-invasive blood tests, such as EasyCheck360, to detect cancer through Circulating Tumor Cells. The company operates by analyzing blood samples for early-stage cancer identification, offering services like screening, diagnosis, therapy guidance, and monitoring. Based in India, the UK, and Germany, it serves asymptomatic adults and healthcare providers with safe, convenient testing that requires no hospitalization. This approach enables early detection for better treatment outcomes.
- Headquarters Nashik, India
- Founders Rajan Datar
- SectorsHealthcare
- Website easycheck360.com
- Social X Facebook
- Legal Name Datar Cancer Genetics Private Limited
- Date of Incorporation 24 Jun, 1992
- Jurisdiction Nashik, Maharashtra, India
- Annual Revenue₹102 Cr
FY 2025 · +31% YoY
- Net Loss-₹3.85 Cr
FY 2025 · -4% margin
- EBITDA₹21.60 Cr
FY 2025 · 21% margin
Associated legal entities of EasyCheck360
EasyCheck360 operates through Datar Cancer Genetics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Datar Cancer Genetics Private Limited CIN U01110MH1992PTC067409 | Active | 24 Jun 1992 | Nashik, Maharashtra | ₹102 Cr | 4 | View details |
Products & Services of EasyCheck360
EasyCheck360 offers a comprehensive portfolio of products and services, including EasyCheck360, Cancertrack, and Exacta.
Detects cancer early using Circulating Tumor Cells analysis.
Tracks cancer treatments for better management.
Assists in making informed treatment decisions.
Board of directors of Datar Cancer Genetics Private Limited (EasyCheck360)
Datar Cancer Genetics Private Limited is the primary company behind EasyCheck360. The board of Datar Cancer Genetics Private Limited currently have 3 directors; the longest-serving is Sneha Rajan Datar, appointed in 2013. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sneha Rajan Datar DIN 01462203 | Director | 01 Apr 2013 | 13 yrs 7 mo | Datar Cancer Genetics Private Limited |
| Swati Satish Deshpande DIN 08312755 | Director | 23 Oct 2020 | 6 yrs | Datar Cancer Genetics Private Limited |
| Rajan Bhalchandra Datar DIN 01530860 | Director | 25 Mar 2022 | 4 yrs 7 mo | Datar Cancer Genetics Private Limited |
People of EasyCheck360
1 people are tracked at EasyCheck360 (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder | Leadership |
Complete people profiles for EasyCheck360
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of EasyCheck360
Figures of Datar Cancer Genetics Private Limited, the primary company behind EasyCheck360, for FY 2025. Revenue was ₹102 Cr (+31% year on year). Net loss was -₹3.85 Cr (-4% margin). EBITDA was ₹21.60 Cr (21% margin). Revenue has grown at a compounded annual rate of +16% over three years and +51% over five years.
- ₹102 CrRevenue · FY 2025 · +31% YoY
- -₹3.85 CrNet loss · -4% margin
- ₹21.60 CrEBITDA · 21% margin
- ₹120 CrPaid-up capital
- +16%Revenue CAGR, 3 years
- +51%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Datar Cancer Genetics Private Limited are on its company page.
Detailed financial statements for EasyCheck360
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of EasyCheck360
The website of EasyCheck360 (easycheck360.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▼ 8.3% vs previous month
Top companies in Clinical Trials & Research Tech
2 companies that operate in the same segment as EasyCheck360 (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | USD 50.52 M | 902 | ||
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | USD 4.22 M | 228 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Easycheck360
Complete news archive for EasyCheck360
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EasyCheck360
EasyCheck360 was founded in 2020.
EasyCheck360 is headquartered in Nashik, India. It is registered at Nashik, Maharashtra, India.
The primary company behind EasyCheck360, Datar Cancer Genetics Private Limited, reported revenue of ₹102 Cr for FY 2025, up 31% year on year.
Datar Cancer Genetics specializes in developing and providing non-invasive blood tests, such as EasyCheck360, to detect cancer through Circulating Tumor Cells. The company operates by analyzing blood samples for early-stage cancer identification, offering services like screening, diagnosis, therapy guidance, and monitoring. Based in India, the UK, and Germany, it serves asymptomatic adults and healthcare providers with safe, convenient testing that requires no hospitalization. This approach enables early detection for better treatment outcomes.
EasyCheck360 offers EasyCheck360, Cancertrack, and Exacta.
EasyCheck360 operates through Datar Cancer Genetics Private Limited.
The legal entities of EasyCheck360 currently have 4 directors, including Sneha Rajan Datar, Swati Satish Deshpande, Rajan Bhalchandra Datar and others.